Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.84 trillion, total revenue of $4.7 trillion and a weighted average PE ratio of 49.33.
Market Cap
9.84T
Revenue
4.7T
Profits
199.42B
PE Ratio
49.33
Profit Margin
4.24%
Dividend Yield
0.38%
1052 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.25T | -0.20% | 1,667,859 | 86.46B |
| 2 | JNJ | Johnson & Johnson | 639.45B | -1.82% | 3,428,225 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 504.25B | -1.21% | 3,064,666 | 66.01B |
| 4 | UNH | UnitedHealth Group Incorporated | 359.75B | 0.09% | 2,306,656 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 354.75B | -3.08% | 5,507,358 | 67.38B |
| 6 | NVS | Novartis AG | 298.68B | -1.49% | 973,361 | 57.36B |
| 7 | AZN | AstraZeneca PLC | 280.95B | -1.89% | 2,165,609 | 62.38B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 258.76B | 2.31% | 1,139,152 | 47.35B |
| 9 | AMGN | Amgen Inc. | 249.06B | -1.02% | 1,157,193 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 208.55B | -1.29% | 3,125,476 | 30.99B |
| 11 | ABT | Abbott Laboratories | 188.68B | -1.02% | 4,943,151 | 48.23B |
| 12 | NVO | Novo Nordisk A/S | 176.81B | -1.00% | 8,151,944 | 50.34B |
| 13 | PFE | Pfizer Inc. | 170.71B | -2.35% | 36,688,825 | 63.63B |
| 14 | DHR | Danaher Corporation | 161.66B | 0.80% | 1,580,101 | 25.61B |
| 15 | ISRG | Intuitive Surgical, Inc. | 152.78B | 0.89% | 1,097,061 | 11.58B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 134.28B | -4.23% | 1,852,117 | 12.95B |
| 17 | BMY | Bristol-Myers Squibb Company | 125.94B | -2.24% | 5,359,284 | 50.03B |
| 18 | MDT | Medtronic plc | 120.96B | -0.48% | 4,548,233 | 37.54B |
| 19 | SYK | Stryker Corporation | 117.63B | 0.71% | 1,832,693 | 26.30B |
| 20 | CVS | CVS Health Corporation | 116.90B | 3.27% | 15,742,222 | 412.65B |
| 21 | MCK | McKesson Corporation | 116.66B | 0.22% | 487,772 | 410.98B |
| 22 | SNY | Sanofi | 107.18B | -0.94% | 4,883,576 | 57.89B |
| 23 | GSK | GSK plc | 97.36B | -0.96% | 2,202,205 | 44.53B |
| 24 | REGN | Regeneron Pharmaceuticals, Inc. | 97.25B | 0.82% | 791,836 | 16.90B |
| 25 | HCA | HCA Healthcare, Inc. | 96.75B | -0.98% | 669,888 | 78.70B |
| 26 | MRNA | Moderna, Inc. | 90.65B | 2.82% | 7,524,801 | 2.23B |
| 27 | ELV | Elevance Health, Inc. | 88.97B | -0.44% | 569,078 | 201.83B |
| 28 | CI | The Cigna Group | 77.85B | -0.19% | 1,037,810 | 282.38B |
| 29 | TAK | Takeda Pharmaceutical Company Limited | 66.76B | -0.77% | 2,136,309 | 29.86B |
| 30 | COR | Cencora, Inc. | 64.87B | 0.63% | 965,634 | 332.77B |
| 31 | BSX | Boston Scientific Corporation | 63.16B | -1.67% | 13,561,856 | 21.07B |
| 32 | CAH | Cardinal Health, Inc. | 58.67B | -0.37% | 894,686 | 254.25B |
| 33 | ARGX | argenx SE | 56.75B | 2.78% | 347,527 | 5.92B |
| 34 | NTRA | Natera, Inc. | 56.14B | 2.79% | 2,653,731 | 2.71B |
| 35 | EW | Edwards Lifesciences Corporation | 54.99B | 2.29% | 4,478,950 | 6.51B |
| 36 | BDX | Becton, Dickinson and Company | 53.78B | -0.59% | 1,148,339 | 22.48B |
| 37 | IDXX | IDEXX Laboratories, Inc. | 53.22B | 0.58% | 552,274 | 4.66B |
| 38 | HUM | Humana Inc. | 50.01B | 1.49% | 927,070 | 145.68B |
| 39 | A | Agilent Technologies, Inc. | 49.65B | 2.39% | 1,431,606 | 7.37B |
| 40 | VEEV | Veeva Systems Inc. | 49.26B | -0.90% | 1,030,334 | 3.46B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 48.65B | 2.58% | 9,298,167 | 17.23B |
| 42 | WAT | Waters Corporation | 45.34B | 2.66% | 1,395,071 | 5.61B |
| 43 | MDLN | Medline Inc. | 44.75B | 1.22% | 10,825,739 | 29.94B |
| 44 | IQV | IQVIA Holdings Inc. | 43.21B | 1.45% | 774,935 | 17.31B |
| 45 | RVMD | Revolution Medicines, Inc. | 41.68B | 3.34% | 808,524 | - |
| 46 | ONC | BeOne Medicines AG | 40.34B | -1.79% | 312,564 | 6.13B |
| 47 | HLN | Haleon plc | 38.86B | 0.97% | 26,299,438 | 14.80B |
| 48 | RPRX | Royalty Pharma plc | 38.09B | -0.41% | 2,103,051 | 2.54B |
| 49 | BIIB | Biogen Inc. | 36.80B | -0.03% | 763,604 | 10.30B |
| 50 | GEHC | GE HealthCare Technologies Inc. | 36.29B | 0.89% | 3,724,838 | 21.64B |
| 51 | ILMN | Illumina, Inc. | 35.89B | 4.76% | 1,510,044 | 4.54B |
| 52 | ALC | Alcon Inc. | 34.66B | -1.66% | 1,422,343 | 10.86B |
| 53 | ZTS | Zoetis Inc. | 34.29B | -0.23% | 2,450,917 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 34.01B | 1.15% | 137,721 | 4.13B |
| 55 | GMAB | Genmab A/S | 33.57B | 0.84% | 2,439,275 | 4.13B |
| 56 | CNC | Centene Corporation | 33.19B | 0.78% | 3,011,899 | 180.41B |
| 57 | RMD | ResMed Inc. | 31.67B | -3.34% | 1,416,761 | 5.73B |
| 58 | DXCM | DexCom, Inc. | 30.95B | -2.11% | 2,027,890 | 5.10B |
| 59 | LH | Labcorp Holdings Inc. | 28.65B | -0.78% | 457,056 | 14.59B |
| 60 | WST | West Pharmaceutical Services, Inc. | 28.56B | 0.52% | 752,309 | 3.40B |
| 61 | PHG | Koninklijke Philips N.V. | 27.72B | 3.28% | 1,807,719 | 20.16B |
| 62 | DGX | Quest Diagnostics Incorporated | 27.04B | -1.99% | 647,792 | 11.84B |
| 63 | ROIV | Roivant Sciences Ltd. | 26.15B | 0.86% | 4,387,056 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 25.79B | 0.85% | 401,802 | 3.15B |
| 65 | INCY | Incyte Corporation | 24.01B | -1.87% | 1,206,314 | 6.01B |
| 66 | GH | Guardant Health, Inc. | 23.39B | 2.08% | 1,312,193 | 1.18B |
| 67 | INSM | Insmed Incorporated | 23.09B | -3.70% | 2,451,962 | 1.52B |
| 68 | STE | STERIS plc | 22.53B | -0.99% | 409,067 | 6.04B |
| 69 | BNTX | BioNTech SE | 21.77B | -0.98% | 894,821 | 2.75B |
| 70 | VTRS | Viatris Inc. | 21.59B | 0.70% | 4,078,057 | 14.74B |
| 71 | ALNY | Alnylam Pharmaceuticals, Inc. | 21.47B | 1.46% | 2,659,167 | 5.01B |
| 72 | THC | Tenet Healthcare Corporation | 21.29B | -0.52% | 834,898 | 22.15B |
| 73 | MEDP | Medpace Holdings, Inc. | 18.67B | 2.95% | 121,428 | 2.84B |
| 74 | RVTY | Revvity, Inc. | 18.47B | 9.20% | 2,536,457 | 2.94B |
| 75 | ZBH | Zimmer Biomet Holdings, Inc. | 18.44B | -0.69% | 1,799,957 | 8.51B |
| 76 | EXEL | Exelixis, Inc. | 17.65B | 3.17% | 2,529,332 | 2.50B |
| 77 | NBIX | Neurocrine Biosciences, Inc. | 16.89B | 14.31% | 3,107,370 | 3.70B |
| 78 | CRL | Charles River Laboratories International, Inc. | 16.82B | 4.05% | 1,155,917 | 4.00B |
| 79 | ASND | Ascendis Pharma A/S | 16.44B | 0.56% | 430,698 | 1.20B |
| 80 | ICLR | ICON Public Limited Company | 15.40B | 0.22% | 715,408 | 8.23B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 15.16B | 8.89% | 1,179,347 | 4.72B |
| 82 | HALO | Halozyme Therapeutics, Inc. | 14.69B | 0.34% | 789,276 | 1.66B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 14.50B | -0.71% | 1,705,216 | 945.54M |
| 84 | BTSG | BrightSpring Health Services, Inc. | 14.47B | 4.86% | 2,773,928 | 15.25B |
| 85 | SOLV | Solventum Corporation | 14.40B | -0.15% | 494,645 | 8.31B |
| 86 | TEM | Tempus AI, Inc. | 14.27B | -0.09% | 5,215,540 | 1.51B |
| 87 | GKOS | Glaukos Corporation | 13.97B | -1.07% | 910,788 | 690.33M |
| 88 | EHC | Encompass Health Corporation | 13.37B | -1.25% | 731,745 | 6.34B |
| 89 | BAX | Baxter International Inc. | 13.11B | 4.62% | 5,549,450 | 11.61B |
| 90 | SMMT | Summit Therapeutics Inc. | 12.83B | 8.41% | 4,820,949 | - |
| 91 | PEN | Penumbra, Inc. | 12.62B | -0.35% | 282,717 | 1.56B |
| 92 | SNN | Smith & Nephew plc | 12.53B | -0.15% | 2,285,274 | 6.30B |
| 93 | ELAN | Elanco Animal Health Incorporated | 12.28B | 1.95% | 4,063,723 | 5.02B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 12.18B | 0.99% | 2,173,151 | 3.44B |
| 95 | COO | The Cooper Companies, Inc. | 11.55B | -0.91% | 1,151,047 | 4.24B |
| 96 | RGEN | Repligen Corporation | 11.44B | 3.46% | 457,670 | 805.61M |
| 97 | TECH | Bio-Techne Corporation | 11.40B | 0.02% | 1,679,054 | 1.22B |
| 98 | DVA | DaVita Inc. | 11.39B | -2.51% | 381,643 | 14.17B |
| 99 | FMS | Fresenius Medical Care AG | 11.09B | -4.20% | 1,765,131 | 22.12B |
| 100 | KYMR | Kymera Therapeutics, Inc. | 10.89B | 0.05% | 919,051 | 102.24M |
| 101 | MOH | Molina Healthcare, Inc. | 10.88B | 0.23% | 639,381 | 42.08B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.78B | -3.01% | 3,297,145 | 3.66B |
| 103 | ALGN | Align Technology, Inc. | 10.76B | -1.76% | 367,947 | 4.16B |
| 104 | PODD | Insulet Corporation | 10.75B | 0.91% | 1,078,830 | 3.05B |
| 105 | GMED | Globus Medical, Inc. | 10.67B | 0.01% | 820,059 | 3.14B |
| 106 | ENSG | The Ensign Group, Inc. | 10.65B | 2.77% | 324,378 | 5.67B |
| 107 | AVTR | Avantor, Inc. | 10.58B | - | 5,161,127 | 6.64B |
| 108 | UHS | Universal Health Services, Inc. | 10.49B | -1.47% | 353,714 | 18.35B |
| 109 | QGEN | Qiagen N.V. | 10.42B | 0.05% | 6,629,911 | 2.10B |
| 110 | BIO | Bio-Rad Laboratories, Inc. | 9.98B | 1.95% | 126,380 | 2.59B |
| 111 | OSCR | Oscar Health, Inc. | 9.96B | 4.21% | 2,841,127 | 15.32B |
| 112 | PCVX | Vaxcyte, Inc. | 9.58B | 0.40% | 1,200,457 | - |
| 113 | HNGE | Hinge Health, Inc. | 9.34B | 0.27% | 2,475,054 | 800.82M |
| 114 | CAI | Caris Life Sciences, Inc. | 9.30B | 2.55% | 1,621,905 | 989.61M |
| 115 | SYRE | Spyre Therapeutics, Inc. | 9.26B | 3.71% | 421,975 | - |
| 116 | MDGL | Madrigal Pharmaceuticals, Inc. | 9.22B | -7.40% | 1,762,621 | 1.43B |
| 117 | HSIC | Henry Schein, Inc. | 9.17B | -4.98% | 3,119,158 | 13.60B |
| 118 | PTGX | Protagonist Therapeutics, Inc. | 9.13B | 1.21% | 214,408 | 281.99M |
| 119 | ATR | AptarGroup, Inc. | 9.06B | -0.67% | 370,145 | 3.99B |
| 120 | KRYS | Krystal Biotech, Inc. | 8.97B | 2.28% | 377,564 | 470.03M |
| 121 | CORT | Corcept Therapeutics Incorporated | 8.95B | 2.95% | 986,486 | 830.81M |
| 122 | TWST | Twist Bioscience Corporation | 8.72B | 7.80% | 1,534,566 | 431.80M |
| 123 | IBRX | ImmunityBio, Inc. | 8.71B | 3.33% | 4,391,041 | 165.79M |
| 124 | CYTK | Cytokinetics, Incorporated | 8.68B | 0.66% | 976,326 | 67.67M |
| 125 | TGTX | TG Therapeutics, Inc. | 8.67B | 1.93% | 977,443 | 799.54M |
| 126 | BRKR | Bruker Corporation | 8.58B | 1.10% | 3,307,394 | 3.50B |
| 127 | HQY | HealthEquity, Inc. | 8.50B | -0.93% | 536,798 | 1.36B |
| 128 | TXG | 10x Genomics, Inc. | 8.49B | 5.71% | 1,751,483 | 616.91M |
| 129 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.42B | 0.10% | 619,794 | 669.50M |
| 130 | ABVX | ABIVAX Société Anonyme | 8.05B | 4.10% | 521,497 | 5.33M |
| 131 | PRAX | Praxis Precision Medicines, Inc. | 7.84B | 2.45% | 118,348 | 7.46M |
| 132 | ALKS | Alkermes plc | 7.79B | 3.46% | 1,478,446 | 1.75B |
| 133 | GRFS | Grifols, S.A. | 7.57B | 0.12% | 765,161 | 8.63B |
| 134 | AXSM | Axsome Therapeutics, Inc. | 7.36B | 2.89% | 1,313,321 | 865.27M |
| 135 | PACS | PACS Group, Inc. | 7.36B | 1.93% | 391,189 | 5.55B |
| 136 | KNSA | Kiniksa Pharmaceuticals International, plc | 7.29B | 2.19% | 799,605 | 945.96M |
| 137 | BLCO | Bausch + Lomb Corporation | 7.15B | -0.10% | 483,933 | 5.42B |
| 138 | AMRX | Amneal Pharmaceuticals, Inc. | 7.00B | -1.61% | 1,689,394 | 3.20B |
| 139 | CHE | Chemed Corporation | 6.91B | -1.60% | 139,073 | 2.66B |
| 140 | IONS | Ionis Pharmaceuticals, Inc. | 6.74B | -1.67% | 2,203,609 | 874.09M |
| 141 | ORKA | Oruka Therapeutics, Inc. | 6.61B | 4.61% | 598,819 | - |
| 142 | LNTH | Lantheus Holdings, Inc. | 6.57B | 0.40% | 457,298 | 1.56B |
| 143 | LGND | Ligand Pharmaceuticals Incorporated | 6.26B | 1.86% | 98,057 | 253.83M |
| 144 | GRAL | GRAIL, Inc. | 6.25B | 4.63% | 321,660 | 165.26M |
| 145 | KOD | Kodiak Sciences Inc. | 6.18B | 0.97% | 499,684 | - |
| 146 | BLTE | Belite Bio, Inc | 6.15B | -0.57% | 127,032 | - |
| 147 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.04B | -6.19% | 5,944,195 | 280.75M |
| 148 | HIMS | Hims & Hers Health, Inc. | 5.99B | 1.74% | 5,432,183 | 2.58B |
| 149 | IMVT | Immunovant, Inc. | 5.98B | 1.95% | 564,919 | - |
| 150 | TFX | Teleflex Incorporated | 5.90B | -1.02% | 789,712 | 2.25B |
| 151 | RDNT | RadNet, Inc. | 5.83B | 1.31% | 454,301 | 2.27B |
| 152 | DOCS | Doximity, Inc. | 5.79B | -1.10% | 888,406 | 655.57M |
| 153 | CGON | CG Oncology, Inc. | 5.70B | 3.70% | 402,908 | 6.23M |
| 154 | PTCT | PTC Therapeutics, Inc. | 5.66B | 11.30% | 1,955,489 | 1.16B |
| 155 | MIRM | Mirum Pharmaceuticals, Inc. | 5.63B | 1.21% | 412,703 | 618.07M |
| 156 | MANE | Veradermics, Incorporated | 5.60B | 3.40% | 367,167 | - |
| 157 | HAE | Haemonetics Corporation | 5.48B | 0.27% | 378,805 | 1.35B |
| 158 | COGT | Cogent Biosciences, Inc. | 5.39B | 4.41% | 1,197,294 | - |
| 159 | SRRK | Scholar Rock Holding Corporation | 5.32B | 1.86% | 299,837 | - |
| 160 | WAY | Waystar Holding Corp. | 5.32B | -1.40% | 2,776,952 | 1.26B |
| 161 | MMED | MiniMed Group, Inc. | 5.27B | -0.98% | 3,551,730 | 3.22B |
| 162 | BLLN | BillionToOne, Inc. | 5.18B | -0.52% | 225,568 | 397.41M |
| 163 | CON | Concentra Group Holdings Parent, Inc. | 5.15B | 0.20% | 505,070 | 2.29B |
| 164 | LFST | LifeStance Health Group, Inc. | 5.12B | 1.13% | 1,582,355 | 1.58B |
| 165 | ERAS | Erasca, Inc. | 5.12B | 4.16% | 2,355,066 | - |
| 166 | MMSI | Merit Medical Systems, Inc. | 5.06B | 0.17% | 476,107 | 1.61B |
| 167 | CRSP | CRISPR Therapeutics AG | 4.81B | -0.52% | 809,508 | 25.17M |
| 168 | OPCH | Option Care Health, Inc. | 4.76B | 0.24% | 1,534,695 | 5.69B |
| 169 | HTFL | HeartFlow, Inc. | 4.75B | 0.19% | 1,043,641 | 212.07M |
| 170 | CDNA | CareDx, Inc. | 4.68B | 3.66% | 1,209,299 | 497.40M |
| 171 | DNTH | Dianthus Therapeutics, Inc. | 4.64B | 0.75% | 258,936 | 1.90M |
| 172 | SHC | Sotera Health Company | 4.59B | -9.36% | 3,631,938 | 1.23B |
| 173 | TVTX | Travere Therapeutics, Inc. | 4.59B | -1.20% | 6,833,298 | 651.03M |
| 174 | DFTX | Definium Therapeutics, Inc. | 4.47B | 2.54% | 1,277,357 | - |
| 175 | LIVN | LivaNova PLC | 4.41B | -0.24% | 508,899 | 1.47B |
| 176 | ITGR | Integer Holdings Corporation | 4.31B | 0.11% | 374,435 | 1.83B |
| 177 | SPUN | Indivior Pharmaceuticals, Inc. | 4.28B | 2.57% | 4,869,435 | 1.37B |
| 178 | LEGN | Legend Biotech Corporation | 4.17B | 1.94% | 574,588 | 1.27B |
| 179 | IRTC | iRhythm Holdings, Inc. | 4.15B | -0.33% | 250,347 | 825.34M |
| 180 | ADPT | Adaptive Biotechnologies Corporation | 4.12B | 3.01% | 989,663 | 308.08M |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 4.10B | -0.94% | 1,239,202 | - |
| 182 | VCYT | Veracyte, Inc. | 4.03B | 2.41% | 508,100 | 561.90M |
| 183 | ICUI | ICU Medical, Inc. | 4.03B | -0.78% | 90,763 | 2.16B |
| 184 | ARQT | Arcutis Biotherapeutics, Inc. | 4.02B | 2.37% | 818,442 | 463.98M |
| 185 | NVST | Envista Holdings Corporation | 3.98B | 0.24% | 4,193,096 | 2.86B |
| 186 | STVN | Stevanato Group S.p.A. | 3.97B | -26.44% | 4,118,364 | 1.42B |
| 187 | TNGX | Tango Therapeutics, Inc. | 3.95B | 7.63% | 1,663,845 | 53.81M |
| 188 | IOVA | Iovance Biotherapeutics, Inc. | 3.95B | 8.60% | 10,523,005 | 324.97M |
| 189 | ABCL | AbCellera Biologics Inc. | 3.90B | 8.27% | 2,029,301 | 66.17M |
| 190 | RLAY | Relay Therapeutics, Inc. | 3.84B | 1.50% | 1,761,470 | 10.35M |
| 191 | LQDA | Liquidia Corporation | 3.74B | -0.12% | 1,304,643 | 450.91M |
| 192 | XENE | Xenon Pharmaceuticals Inc. | 3.72B | 2.07% | 800,612 | 7.50M |
| 193 | PLSE | Pulse Biosciences, Inc. | 3.69B | -2.27% | 228,456 | 1.19M |
| 194 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.66B | 3.96% | 737,800 | -665.00K |
| 195 | OGN | Organon & Co. | 3.64B | 0.18% | 2,099,877 | 6.10B |
| 196 | PBLS | Parabilis Medicines, Inc. | 3.61B | 7.27% | 329,758 | 148.00K |
| 197 | IRON | Disc Medicine, Inc. | 3.61B | 3.36% | 520,571 | - |
| 198 | ACAD | Acadia Pharmaceuticals Inc. | 3.56B | 0.95% | 922,484 | 1.14B |
| 199 | CELC | Celcuity Inc. | 3.41B | 3.95% | 460,279 | - |
| 200 | DYN | Dyne Therapeutics, Inc. | 3.35B | 3.82% | 1,556,449 | - |
| 201 | VKTX | Viking Therapeutics, Inc. | 3.33B | -2.76% | 2,014,237 | - |
| 202 | ELVN | Enliven Therapeutics, Inc. | 3.28B | 0.25% | 407,281 | - |
| 203 | NHC | National HealthCare Corporation | 3.18B | 0.54% | 91,630 | 1.56B |
| 204 | TARS | Tarsus Pharmaceuticals, Inc. | 3.13B | -2.58% | 485,006 | 606.33M |
| 205 | DNLI | Denali Therapeutics Inc. | 3.08B | 2.28% | 1,368,333 | 3.60M |
| 206 | ATRC | AtriCure, Inc. | 3.07B | 0.81% | 1,139,583 | 569.62M |
| 207 | TLX | Telix Pharmaceuticals Limited | 3.07B | -0.28% | 130,715 | 890.79M |
| 208 | RGC | Regencell Bioscience Holdings Limited | 3.05B | -2.07% | 83,001 | - |
| 209 | BHC | Bausch Health Companies Inc. | 3.04B | 1.25% | 2,490,294 | 11.11B |
| 210 | IDYA | IDEAYA Biosciences, Inc. | 3.02B | -0.95% | 1,153,737 | 36.54M |
| 211 | SGRY | Surgery Partners, Inc. | 3.00B | 0.13% | 1,491,093 | 3.37B |
| 212 | AXGN | Axogen, Inc. | 2.94B | -1.16% | 646,377 | 266.93M |
| 213 | AVAH | Aveanna Healthcare Holdings Inc. | 2.91B | 1.60% | 1,153,520 | 2.60B |
| 214 | VRDN | Viridian Therapeutics, Inc. | 2.84B | -0.75% | 3,030,500 | 71.13M |
| 215 | NRIX | Nurix Therapeutics, Inc. | 2.81B | - | 1,235,665 | 701.94M |
| 216 | ACHC | Acadia Healthcare Company, Inc. | 2.77B | 0.61% | 769,387 | 3.37B |
| 217 | PRVA | Privia Health Group, Inc. | 2.74B | 0.85% | 628,161 | 2.36B |
| 218 | ZLAB | Zai Lab Limited | 2.72B | 0.97% | 631,673 | 449.61M |
| 219 | WRBY | Warby Parker Inc. | 2.70B | -8.30% | 2,569,377 | 911.61M |
| 220 | RCUS | Arcus Biosciences, Inc. | 2.70B | 5.15% | 1,144,647 | 117.00M |
| 221 | MBX | MBX Biosciences, Inc. | 2.65B | 1.32% | 158,922 | - |
| 222 | NEOG | Neogen Corporation | 2.65B | 2.62% | 1,305,005 | 884.00M |
| 223 | BEAM | Beam Therapeutics Inc. | 2.65B | 2.40% | 671,842 | 146.64M |
| 224 | GRDN | Guardian Pharmacy Services, Inc. | 2.59B | 2.13% | 362,555 | 1.46B |
| 225 | BKD | Brookdale Senior Living Inc. | 2.50B | 0.19% | 3,474,882 | 2.93B |
| 226 | ADMA | ADMA Biologics, Inc. | 2.48B | - | 3,723,927 | 512.28M |
| 227 | PHVS | Pharvaris N.V. | 2.45B | 4.12% | 341,863 | - |
| 228 | IMNM | Immunome, Inc. | 2.40B | 3.62% | 1,294,502 | 4.02M |
| 229 | NAMS | NewAmsterdam Pharma Company N.V. | 2.39B | 2.35% | 1,685,687 | 7.12M |
| 230 | HCM | HUTCHMED (China) Limited | 2.34B | -1.81% | 20,456 | 549.12M |
| 231 | MD | Pediatrix Medical Group, Inc. | 2.34B | -0.18% | 692,948 | 1.96B |
| 232 | BHVN | Biohaven Ltd. | 2.34B | 1.98% | 1,337,301 | - |
| 233 | PBH | Prestige Consumer Healthcare Inc. | 2.34B | -0.88% | 290,129 | 1.10B |
| 234 | CLDX | Celldex Therapeutics, Inc. | 2.33B | 2.24% | 554,421 | 158.00K |
| 235 | TMDX | TransMedics Group, Inc. | 2.32B | 0.54% | 433,293 | 668.47M |
| 236 | ADUS | Addus HomeCare Corporation | 2.30B | 0.10% | 333,634 | 1.48B |
| 237 | XNCR | Xencor, Inc. | 2.29B | 3.64% | 847,843 | 104.97M |
| 238 | CLOV | Clover Health Investments, Corp. | 2.27B | -0.70% | 2,983,653 | 2.48B |
| 239 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 2.91% | 811,699 | 321.74M |
| 240 | PGNY | Progyny, Inc. | 2.22B | -1.46% | 490,332 | 1.31B |
| 241 | TRLV | Trulieve Cannabis Corp. | 2.22B | 3.69% | 1,097,471 | 1.14B |
| 242 | VERA | Vera Therapeutics, Inc. | 2.21B | 1.29% | 1,119,981 | - |
| 243 | RXRX | Recursion Pharmaceuticals, Inc. | 2.21B | -3.66% | 16,827,207 | 68.23M |
| 244 | NEO | NeoGenomics, Inc. | 2.20B | 2.97% | 545,808 | 787.75M |
| 245 | PVLA | Palvella Therapeutics, Inc. | 2.19B | 3.99% | 237,614 | - |
| 246 | UFPT | UFP Technologies, Inc. | 2.19B | -0.43% | 97,179 | 631.64M |
| 247 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.19B | 3.88% | 4,257,558 | 940.61M |
| 248 | PRGO | Perrigo Company plc | 2.17B | -0.76% | 1,015,936 | 4.14B |
| 249 | ZYME | Zymeworks Inc. | 2.14B | 4.17% | 979,471 | 37.13M |
| 250 | HRMY | Harmony Biosciences Holdings, Inc. | 2.13B | -3.59% | 774,157 | 959.90M |
| 251 | VCEL | Vericel Corporation | 2.10B | 1.09% | 336,661 | 306.30M |
| 252 | ALMR | Alamar Biosciences, Inc. | 2.09B | 4.04% | 448,528 | 100.42M |
| 253 | WGS | GeneDx Holdings Corp. | 2.05B | 7.40% | 269,791 | 454.43M |
| 254 | LKFT | Lakefront Biotherapeutics NV | 2.04B | 0.09% | 74,945 | 1.13B |
| 255 | SEPN | Septerna, Inc. | 2.02B | 0.25% | 188,735 | 98.88M |
| 256 | SDGR | Schrödinger, Inc. | 2.02B | 3.13% | 787,476 | 259.04M |
| 257 | FTRE | Fortrea Holdings Inc. | 2.01B | 4.20% | 854,195 | 2.67B |
| 258 | MESO | Mesoblast Limited | 2.00B | 1.79% | 220,154 | 120.25M |
| 259 | COAG | Hemab Therapeutics Holdings, Inc. | 1.99B | 3.50% | 287,657 | - |
| 260 | TRVI | Trevi Therapeutics, Inc. | 1.96B | 1.17% | 764,065 | - |
| 261 | SRPT | Sarepta Therapeutics, Inc. | 1.96B | 1.47% | 549,996 | 1.97B |
| 262 | XRAY | DENTSPLY SIRONA Inc. | 1.94B | -1.62% | 2,063,156 | 3.64B |
| 263 | TRAX | First Tracks Biotherapeutics, Inc. | 1.94B | 2.38% | 258,242 | - |
| 264 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.93B | 3.48% | 1,048,825 | 208.78M |
| 265 | REPL | Replimune Group, Inc. | 1.93B | 4.52% | 3,814,831 | - |
| 266 | XERS | Xeris Biopharma Holdings, Inc. | 1.90B | 2.56% | 1,463,204 | 335.41M |
| 267 | VIR | Vir Biotechnology, Inc. | 1.90B | 1.91% | 960,547 | 303.23M |
| 268 | AGIO | Agios Pharmaceuticals, Inc. | 1.88B | 5.01% | 349,360 | 98.34M |
| 269 | ASTH | Astrana Health, Inc. | 1.86B | -1.30% | 183,989 | 3.84B |
| 270 | LMAT | LeMaitre Vascular, Inc. | 1.86B | -0.13% | 160,176 | 262.43M |
| 271 | ZBIO | Zenas BioPharma, Inc. | 1.85B | 2.82% | 271,309 | 1.00M |
| 272 | PGEN | Precigen, Inc. | 1.83B | -0.68% | 7,837,085 | 85.72M |
| 273 | ESTA | Establishment Labs Holdings Inc. | 1.82B | -0.07% | 333,846 | 264.03M |
| 274 | ADRX | ADARx Pharmaceuticals, Inc. | 1.81B | 2.73% | 278,385 | 6.13M |
| 275 | INSP | Inspire Medical Systems, Inc. | 1.79B | -7.65% | 1,097,293 | 880.94M |
| 276 | SLS | SELLAS Life Sciences Group, Inc. | 1.78B | 3.16% | 4,159,927 | - |
| 277 | GENB | Generate Biomedicines, Inc. | 1.76B | 3.60% | 507,264 | 26.48M |
| 278 | AMN | AMN Healthcare Services, Inc. | 1.75B | -1.05% | 353,562 | 3.43B |
| 279 | STOK | Stoke Therapeutics, Inc. | 1.75B | 1.89% | 1,112,972 | 28.21M |
| 280 | KMTS | Kestra Medical Technologies, Ltd. | 1.74B | -2.00% | 237,239 | 106.73M |
| 281 | HCSG | Healthcare Services Group, Inc. | 1.74B | - | 465,088 | 1.88B |
| 282 | BRVE | Braveheart Bio, Inc. | 1.73B | 0.81% | 176,875 | - |
| 283 | MAZE | Maze Therapeutics, Inc. | 1.73B | 5.43% | 347,444 | 20.00M |
| 284 | BFLY | Butterfly Network, Inc. | 1.71B | 4.40% | 2,667,569 | 123.26M |
| 285 | ABSI | Absci Corporation | 1.69B | 1.86% | 1,942,708 | 1.56M |
| 286 | PSNL | Personalis, Inc. | 1.69B | 0.16% | 2,021,118 | 69.67M |
| 287 | URGN | UroGen Pharma Ltd. | 1.68B | -0.20% | 823,900 | 188.73M |
| 288 | SUPN | Supernus Pharmaceuticals, Inc. | 1.68B | -14.86% | 5,033,757 | 865.11M |
| 289 | CERT | Certara, Inc. | 1.65B | 1.26% | 1,097,365 | 421.75M |
| 290 | QURE | uniQure N.V. | 1.65B | 3.79% | 1,241,766 | 18.67M |
| 291 | ARDT | Ardent Health, Inc. | 1.65B | -0.51% | 146,979 | 6.41B |
| 292 | NTLA | Intellia Therapeutics, Inc. | 1.64B | 0.60% | 1,903,550 | 59.51M |
| 293 | RARE | Ultragenyx Pharmaceutical Inc. | 1.64B | 2.33% | 2,635,397 | 717.00M |
| 294 | AZTA | Azenta, Inc. | 1.64B | 5.06% | 621,325 | 613.81M |
| 295 | KLRA | Kailera Therapeutics, Inc. | 1.63B | 3.66% | 496,248 | - |
| 296 | ALVO | Alvotech | 1.62B | 1.56% | 358,443 | 494.61M |
| 297 | OMCL | Omnicell, Inc. | 1.62B | -2.36% | 512,258 | 1.24B |
| 298 | NUVB | Nuvation Bio Inc. | 1.62B | 0.54% | 3,331,380 | 169.90M |
| 299 | SNDA | Sonida Senior Living, Inc. | 1.62B | 0.92% | 252,072 | 481.07M |
| 300 | TDOC | Teladoc Health, Inc. | 1.62B | 2.67% | 4,183,039 | 2.47B |
| 301 | NVAX | Novavax, Inc. | 1.59B | 1.15% | 2,525,596 | 413.80M |
| 302 | LYCA | Lycia Therapeutics, Inc. | 1.58B | 0.72% | 146,538 | 4.44M |
| 303 | NVCR | NovoCure Limited | 1.56B | 0.87% | 797,585 | 725.39M |
| 304 | ALHC | Alignment Healthcare, Inc. | 1.55B | 5.79% | 2,927,476 | 4.94B |
| 305 | IMCR | Immunocore Holdings plc | 1.55B | 0.91% | 143,328 | 430.78M |
| 306 | ANIP | ANI Pharmaceuticals, Inc. | 1.54B | 1.56% | 179,560 | 978.38M |
| 307 | PAHC | Phibro Animal Health Corporation | 1.53B | -2.84% | 190,732 | 1.52B |
| 308 | OCUL | Ocular Therapeutix, Inc. | 1.52B | 2.82% | 1,068,187 | 52.06M |
| 309 | INVA | Innoviva, Inc. | 1.52B | -0.14% | 355,554 | 440.00M |
| 310 | RAPP | Rapport Therapeutics, Inc. | 1.51B | 1.63% | 498,872 | 20.00M |
| 311 | TYRA | Tyra Biosciences, Inc. | 1.46B | -0.19% | 204,949 | - |
| 312 | AGL | agilon health, inc. | 1.46B | 0.51% | 246,860 | 5.92B |
| 313 | ETON | Eton Pharmaceuticals, Inc. | 1.46B | 0.49% | 213,379 | 105.60M |
| 314 | KRSA | Korsana Biosciences, Inc. | 1.46B | 1.11% | 129,866 | - |
| 315 | NBTX | Nanobiotix S.A. | 1.46B | 1.14% | 157,055 | 13.15M |
| 316 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.01% | 821,501 | 746.16M |
| 317 | GPCR | Structure Therapeutics Inc. | 1.45B | -0.78% | 439,326 | - |
| 318 | PNTG | The Pennant Group, Inc. | 1.43B | 1.33% | 123,388 | 1.10B |
| 319 | ANAB | AnaptysBio, Inc. | 1.42B | 1.60% | 139,839 | 106.09M |
| 320 | MLYS | Mineralys Therapeutics, Inc. | 1.41B | 2.22% | 2,009,717 | - |
| 321 | CNMD | CONMED Corporation | 1.40B | 0.73% | 274,370 | 1.37B |
| 322 | GHRS | GH Research PLC | 1.38B | -1.66% | 414,743 | - |
| 323 | DMRA | Damora Therapeutics, Inc. | 1.37B | 2.82% | 279,339 | - |
| 324 | KARD | Kardigan, Inc. | 1.33B | 0.21% | 335,049 | - |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.32B | 1.50% | 965,923 | 5.49M |
| 326 | LBRX | LB Pharmaceuticals Inc | 1.31B | 3.80% | 157,725 | - |
| 327 | OMER | Omeros Corporation | 1.30B | 0.84% | 394,733 | 38.42M |
| 328 | SNDX | Syndax Pharmaceuticals, Inc. | 1.29B | 10.08% | 3,756,976 | 289.68M |
| 329 | OPK | OPKO Health, Inc. | 1.29B | 0.29% | 2,727,717 | 587.90M |
| 330 | NKTR | Nektar Therapeutics | 1.28B | 1.57% | 215,357 | 54.59M |
| 331 | USPH | U.S. Physical Therapy, Inc. | 1.27B | 0.29% | 76,186 | 804.27M |
| 332 | CRON | Cronos Group Inc. | 1.26B | 1.95% | 834,056 | 179.09M |
| 333 | DRTS | Alpha Tau Medical Ltd. | 1.26B | 6.16% | 507,101 | - |
| 334 | STAA | STAAR Surgical Company | 1.26B | 0.44% | 440,002 | 339.59M |
| 335 | AAPG | Ascentage Pharma Group International | 1.25B | 1.11% | 1,738 | 94.61M |
| 336 | FRNM | Freenome, Inc. | 1.24B | -0.39% | 391,678 | 35.41M |
| 337 | NUTX | Nutex Health Inc. | 1.23B | -3.20% | 137,952 | 846.72M |
| 338 | TNDM | Tandem Diabetes Care, Inc. | 1.23B | -5.41% | 1,661,842 | 1.04B |
| 339 | VOR | Vor Biopharma Inc. | 1.23B | 3.58% | 604,563 | - |
| 340 | INNV | InnovAge Holding Corp. | 1.21B | -0.45% | 375,428 | 989.71M |
| 341 | ENOV | Enovis Corporation | 1.21B | 1.75% | 1,216,219 | 2.30B |
| 342 | SVRA | Savara Inc. | 1.21B | 0.63% | 1,522,042 | - |
| 343 | GDRX | GoodRx Holdings, Inc. | 1.20B | -1.13% | 725,978 | 785.23M |
| 344 | MNKD | MannKind Corporation | 1.20B | 1.92% | 3,167,537 | 393.63M |
| 345 | INBX | Inhibrx Biosciences, Inc. | 1.19B | 12.38% | 312,749 | 1.30M |
| 346 | SLN | Silence Therapeutics plc | 1.19B | 0.20% | 268,534 | 615.00K |
| 347 | VSTM | Verastem, Inc. | 1.19B | 1.77% | 1,707,018 | 87.53M |
| 348 | AVLN | Avalyn Pharma Inc. | 1.18B | 4.10% | 341,842 | - |
| 349 | CMPS | COMPASS Pathways plc | 1.18B | 1.07% | 7,674,637 | - |
| 350 | ATEC | Alphatec Holdings, Inc. | 1.16B | 2.46% | 4,722,277 | 839.72M |
| 351 | PRCT | PROCEPT BioRobotics Corporation | 1.16B | 4.22% | 670,079 | 337.34M |
| 352 | AORT | Artivion, Inc. | 1.16B | 0.81% | 347,406 | 471.47M |
| 353 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.15B | 0.18% | 328,388 | 730.02M |
| 354 | SGP | SpyGlass Pharma, Inc. | 1.15B | 2.26% | 145,242 | - |
| 355 | OMDA | Omada Health, Inc. | 1.13B | 3.53% | 325,971 | 309.76M |
| 356 | CBLL | CeriBell, Inc. | 1.09B | 5.60% | 466,878 | 101.96M |
| 357 | JANX | Janux Therapeutics, Inc. | 1.08B | 1.49% | 252,076 | 24.00M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.07B | 0.25% | 267,868 | - |
| 359 | CSTL | Castle Biosciences, Inc. | 1.07B | 0.54% | 276,654 | 357.28M |
| 360 | LMRI | Lumexa Imaging Holdings, Inc. | 1.07B | -0.45% | 144,743 | 1.04B |
| 361 | HROW | Harrow, Inc. | 1.06B | 0.32% | 297,688 | 275.59M |
| 362 | IART | Integra LifeSciences Holdings Corporation | 1.06B | -0.29% | 781,514 | 1.66B |
| 363 | SIBN | SI-BONE, Inc. | 1.05B | 16.00% | 2,694,206 | 220.65M |
| 364 | AHG | Akso Health Group | 1.04B | -7.81% | 2,055 | 13.83M |
| 365 | IRMD | IRADIMED CORPORATION | 1.03B | 1.52% | 106,074 | 89.34M |
| 366 | ODTX | Odyssey Therapeutics, Inc. | 1.03B | 9.63% | 280,298 | 99.00K |
| 367 | ORIC | ORIC Pharmaceuticals, Inc. | 1.01B | 7.39% | 2,472,671 | - |
| 368 | CGEM | Cullinan Therapeutics, Inc. | 1.01B | 4.82% | 455,307 | - |
| 369 | IVA | Inventiva S.A. | 1.00B | 6.53% | 3,641,864 | 2.81M |
| 370 | MLTX | MoonLake Immunotherapeutics | 993.20M | 1.74% | 601,621 | - |
| 371 | HSTM | HealthStream, Inc. | 975.40M | -7.81% | 522,177 | 327.95M |
| 372 | LTGO | Latigo Biotherapeutics, Inc. | 972.94M | 8.62% | 180,565 | - |
| 373 | IMTX | Immatics N.V. | 966.40M | 0.14% | 1,172,030 | 47.65M |
| 374 | QDEL | QuidelOrtho Corporation | 951.83M | -1.07% | 2,267,230 | 2.67B |
| 375 | CTY | City Therapeutics, Inc. | 942.89M | -9.24% | 237,357 | 14.34M |
| 376 | JBIO | Jade Biosciences, Inc. | 926.61M | 4.59% | 1,144,459 | - |
| 377 | BVS | Bioventus Inc. | 918.70M | -16.92% | 2,150,547 | 585.64M |
| 378 | RIGL | Rigel Pharmaceuticals, Inc. | 909.15M | -3.68% | 211,881 | 276.79M |
| 379 | PHAR | Pharming Group N.V. | 907.17M | 1.02% | 20,868 | 386.75M |
| 380 | MGTX | MeiraGTx Holdings plc | 904.73M | 1.07% | 247,767 | 397.50M |
| 381 | GLUE | Monte Rosa Therapeutics, Inc. | 891.53M | -1.69% | 806,534 | 28.73M |
| 382 | ANRO | Alto Neuroscience, Inc. | 887.46M | 1.92% | 348,009 | - |
| 383 | GMRS | GMR Solutions Inc. | 883.70M | 2.34% | 368,938 | 5.88B |
| 384 | KURA | Kura Oncology, Inc. | 873.15M | 0.26% | 779,874 | 77.23M |
| 385 | ALMS | Alumis Inc. | 841.33M | 1.88% | 2,094,470 | 7.40M |
| 386 | BBTX | Bambusa Therapeutics, Inc. | 826.29M | 1.37% | 184,021 | - |
| 387 | CRVS | Corvus Pharmaceuticals, Inc. | 825.23M | 1.13% | 479,796 | - |
| 388 | OBX | Obsidian Therapeutics, Inc. | 820.34M | -7.97% | 463,794 | - |
| 389 | BBNX | Beta Bionics, Inc. | 817.68M | -5.41% | 383,241 | 127.27M |
| 390 | AHCO | AdaptHealth Corp. | 811.79M | 2.96% | 5,642,888 | 3.44B |
| 391 | AKTS | Aktis Oncology, Inc. | 810.38M | -0.14% | 370,559 | 10.06M |
| 392 | INMD | InMode Ltd. | 808.75M | 2.70% | 520,066 | 374.63M |
| 393 | KIDS | OrthoPediatrics Corp. | 805.25M | 1.35% | 468,169 | 264.14M |
| 394 | PRME | Prime Medicine, Inc. | 791.67M | 0.23% | 3,203,160 | 4.07M |
| 395 | ANNX | Annexon, Inc. | 787.70M | 5.46% | 3,146,700 | - |
| 396 | VREX | Varex Imaging Corporation | 781.42M | 0.43% | 538,972 | 865.00M |
| 397 | CTKB | Cytek Biosciences, Inc. | 773.40M | 3.12% | 642,519 | 206.71M |
| 398 | COLL | Collegium Pharmaceutical, Inc. | 771.57M | 0.08% | 254,515 | 808.21M |
| 399 | ABUS | Arbutus Biopharma Corporation | 770.62M | -2.62% | 1,554,729 | 181.72M |
| 400 | PHR | Phreesia, Inc. | 764.09M | -1.05% | 221,517 | 507.79M |
| 401 | PACB | Pacific Biosciences of California, Inc. | 763.09M | 4.69% | 4,919,531 | 159.27M |
| 402 | ARDX | Ardelyx, Inc. | 755.04M | - | 3,596,494 | 450.89M |
| 403 | OABI | OmniAb, Inc. | 735.14M | -0.98% | 1,090,168 | 40.21M |
| 404 | SANA | Sana Biotechnology, Inc. | 721.46M | 0.42% | 1,235,308 | - |
| 405 | DNA | Ginkgo Bioworks Holdings, Inc. | 716.50M | 8.02% | 1,909,069 | 132.42M |
| 406 | SLBT | SL Science Holding Limited | 712.83M | -1.57% | 6,417 | 3.27M |
| 407 | WVE | Wave Life Sciences, Inc. | 704.11M | 1.42% | 1,687,233 | 70.92M |
| 408 | DBVT | DBV Technologies S.A. | 703.83M | 11.99% | 258,981 | 3.74M |
| 409 | ATTO | Attovia Therapeutics, Inc. | 701.66M | 2.13% | 87,842 | 1.80M |
| 410 | SGMT | Sagimet Biosciences Inc. | 699.51M | 1.81% | 421,571 | - |
| 411 | ACHV | Achieve Life Sciences, Inc. | 691.50M | 1.66% | 606,562 | - |
| 412 | SLDB | Solid Biosciences Inc. | 674.45M | 4.83% | 516,405 | - |
| 413 | CADL | Candel Therapeutics, Inc. | 669.54M | 7.76% | 2,762,531 | - |
| 414 | FDMT | 4D Molecular Therapeutics, Inc. | 656.85M | 4.57% | 442,965 | 92.01M |
| 415 | HELP | Helus Pharma Inc. | 653.52M | 1.65% | 1,040,889 | - |
| 416 | DSGN | Design Therapeutics, Inc. | 650.22M | 2.36% | 107,099 | - |
| 417 | AVBP | ArriVent BioPharma, Inc. | 646.42M | -1.80% | 786,021 | - |
| 418 | AURA | Aura Biosciences, Inc. | 646.08M | 3.32% | 421,180 | - |
| 419 | LXRX | Lexicon Pharmaceuticals, Inc. | 645.19M | 0.69% | 500,393 | 41.47M |
| 420 | STLN | Starling Oncology, Inc. | 642.58M | 0.88% | 743,496 | 587.24M |
| 421 | OLMA | Olema Pharmaceuticals, Inc. | 640.48M | 3.54% | 798,190 | - |
| 422 | IMMX | Immix Biopharma, Inc. | 638.35M | 6.06% | 758,499 | - |
| 423 | IAM | Iambic Therapeutics, Inc. | 633.96M | 3.24% | 193,552 | 18.25M |
| 424 | NVCT | Nuvectis Pharma, Inc. | 631.43M | 1.04% | 96,232 | - |
| 425 | APMD | Apnimed, Inc. | 630.29M | -1.69% | 493,213 | 115.12M |
| 426 | ANL | Adlai Nortye Group Ltd. | 609.20M | 0.96% | 203,266 | 18.06M |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 608.68M | 1.49% | 450,570 | 136.07M |
| 428 | GERN | Geron Corporation | 600.71M | 0.64% | 5,302,863 | 204.56M |
| 429 | BCAX | Bicara Therapeutics Inc. | 593.57M | 13.11% | 1,760,622 | - |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 582.47M | 1.88% | 1,446,545 | 389.32M |
| 431 | SOPH | SOPHiA GENETICS SA | 581.42M | -3.94% | 2,209,410 | 90.97M |
| 432 | EVO | Evotec SE | 576.51M | 1.32% | 26,936 | 819.47M |
| 433 | ACRS | Aclaris Therapeutics, Inc. | 574.99M | -2.37% | 1,274,514 | 8.22M |
| 434 | MYGN | Myriad Genetics, Inc. | 571.51M | 2.14% | 643,999 | 806.60M |
| 435 | TCMD | Tactile Systems Technology, Inc. | 564.49M | 8.96% | 356,037 | 356.42M |
| 436 | CBIO | Crescent Biopharma, Inc. | 562.83M | 1.86% | 76,861 | 11.88M |
| 437 | AVR | Anteris Technologies Global Corp. | 553.28M | -1.82% | 902,517 | 2.24M |
| 438 | CLYM | Climb Bio, Inc. | 551.96M | -1.33% | 332,470 | - |
| 439 | STTK | Shattuck Labs, Inc. | 543.97M | 1.88% | 337,187 | 1.00M |
| 440 | VALN | Valneva SE | 543.27M | 3.20% | 3,845 | 163.30M |
| 441 | NGNE | Neurogene Inc. | 534.50M | 0.38% | 133,630 | 925.00K |
| 442 | DMAC | DiaMedica Therapeutics Inc. | 533.33M | 6.46% | 138,717 | - |
| 443 | FLGT | Fulgent Genetics, Inc. | 531.32M | 0.10% | 150,069 | 323.93M |
| 444 | PBYI | Puma Biotechnology, Inc. | 525.49M | - | 278,700 | 231.24M |
| 445 | ENTX | Entera Bio Ltd. | 525.25M | -2.27% | 109,554 | 42.00K |
| 446 | SRZN | Surrozen, Inc. | 520.74M | 2.57% | 80,755 | 11.51M |
| 447 | SGHT | Sight Sciences, Inc. | 518.93M | 2.95% | 201,348 | 83.38M |
| 448 | FTH | Faeth Therapeutics, Inc. | 515.00M | 3.64% | 153,718 | - |
| 449 | NRC | NRC Health | 507.62M | -1.40% | 74,753 | 143.79M |
| 450 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 451 | DCTH | Delcath Systems, Inc. | 502.79M | 1.40% | 253,668 | 95.42M |
| 452 | INDP | Indaptus Therapeutics, Inc. | 499.91M | -7.00% | 89,510 | - |
| 453 | RGNX | REGENXBIO Inc. | 497.74M | 5.31% | 561,376 | 174.48M |
| 454 | ANGO | AngioDynamics, Inc. | 496.66M | 0.43% | 389,098 | 325.38M |
| 455 | ETRA | Electra Therapeutics, Inc. | 491.47M | 7.11% | 726,345 | - |
| 456 | EVH | Evolent Health, Inc. | 489.55M | -2.70% | 724,858 | 2.10B |
| 457 | AQST | Aquestive Therapeutics, Inc. | 486.99M | 2.92% | 1,110,810 | 54.09M |
| 458 | EOLS | Evolus, Inc. | 480.85M | 1.68% | 260,583 | 316.49M |
| 459 | CAPR | Capricor Therapeutics, Inc. | 475.58M | 12.98% | 3,299,714 | 11.13M |
| 460 | GYRE | Gyre Therapeutics, Inc. | 475.56M | -5.18% | 197,243 | 109.82M |
| 461 | RCEL | AVITA Medical, Inc. | 475.35M | -0.26% | 426,778 | 75.63M |
| 462 | OCS | Oculis Holding AG | 471.63M | -0.91% | 441,752 | 1.45M |
| 463 | CTMX | CytomX Therapeutics, Inc. | 470.66M | -3.14% | 2,730,974 | 18.30M |
| 464 | OVID | Ovid Therapeutics Inc. | 468.71M | 0.42% | 940,589 | 1.58M |
| 465 | SENS | Senseonics Holdings, Inc. | 465.82M | -1.89% | 260,044 | 48.55M |
| 466 | CERS | Cerus Corporation | 465.52M | -2.12% | 2,898,269 | 226.57M |
| 467 | MNPR | Monopar Therapeutics Inc. | 465.42M | 4.62% | 113,779 | - |
| 468 | MDXG | MiMedx Group, Inc. | 461.85M | -3.51% | 1,064,585 | 303.73M |
| 469 | ARVN | Arvinas, Inc. | 459.66M | -6.52% | 1,213,711 | 275.30M |
| 470 | SSII | SS Innovations International, Inc. | 458.88M | -0.87% | 33,943 | 52.40M |
| 471 | RLMD | Relmada Therapeutics, Inc. | 453.35M | 10.68% | 1,669,990 | - |
| 472 | TKNO | Alpha Teknova, Inc. | 452.90M | 4.71% | 123,277 | 43.70M |
| 473 | YDES | YD Bio Limited | 451.90M | 6.87% | 20,854 | 1.24M |
| 474 | EPRX | Eupraxia Pharmaceuticals Inc. | 449.81M | 1.78% | 404,104 | - |
| 475 | BWAY | BrainsWay Ltd. | 446.58M | -0.27% | 32,466 | 60.70M |
| 476 | PHAT | Phathom Pharmaceuticals, Inc. | 440.84M | -6.17% | 1,440,832 | 274.88M |
| 477 | MASS | 908 Devices Inc. | 437.72M | 3.72% | 181,287 | 60.84M |
| 478 | CRMD | CorMedix Inc. | 429.86M | 2.32% | 1,888,198 | 462.25M |
| 479 | PRTA | Prothena Corporation plc | 422.50M | -0.72% | 146,072 | 54.53M |
| 480 | RZLT | Rezolute, Inc. | 419.59M | 3.09% | 677,874 | - |
| 481 | NPCE | NeuroPace, Inc. | 412.58M | -2.59% | 155,607 | 106.99M |
| 482 | SI | Shoulder Innovations, Inc. | 406.49M | 1.06% | 76,616 | 60.06M |
| 483 | ASMB | Assembly Biosciences, Inc. | 401.10M | 0.97% | 84,222 | 74.85M |
| 484 | BLSM | BlossomHill Therapeutics, Inc. | 399.85M | 1.29% | 91,066 | - |
| 485 | EDIT | Editas Medicine, Inc. | 399.31M | 1.17% | 1,345,075 | 47.01M |
| 486 | KMDA | Kamada Ltd. | 398.78M | -1.63% | 293,895 | 191.85M |
| 487 | ALT | Altimmune, Inc. | 396.82M | 0.99% | 1,487,279 | 31.00K |
| 488 | CARL | Carlsmed, Inc. | 395.89M | -3.46% | 89,190 | 63.30M |
| 489 | SRTA | Strata Critical Medical, Inc. | 393.68M | 3.97% | 1,493,413 | 280.76M |
| 490 | CCCC | C4 Therapeutics, Inc. | 392.45M | -0.62% | 1,288,750 | 35.04M |
| 491 | PRLD | Prelude Therapeutics Incorporated | 389.32M | -1.56% | 118,743 | 22.42M |
| 492 | MPLT | MapLight Therapeutics, Inc. | 388.20M | 3.02% | 248,635 | - |
| 493 | AVTX | Avalo Therapeutics, Inc. | 387.21M | -1.37% | 1,353,398 | 59.00K |
| 494 | TLRY | Tilray Brands, Inc. | 387.19M | 3.53% | 4,562,945 | 963.10M |
| 495 | ALLO | Allogene Therapeutics, Inc. | 385.22M | 2.29% | 15,988,698 | 4.64M |
| 496 | ZURA | Zura Bio Limited | 380.97M | 0.38% | 1,572,404 | - |
| 497 | FENC | Fennec Pharmaceuticals Inc. | 376.97M | 1.99% | 106,451 | 59.22M |
| 498 | AUTL | Autolus Therapeutics plc | 372.63M | -1.41% | 2,472,423 | 117.39M |
| 499 | TRXB | TRex Bio, Inc. | 372.06M | 1.32% | 126,260 | - |
| 500 | TECX | Tectonic Therapeutic, Inc. | 370.46M | -0.16% | 112,587 | - |